Hypertrophic Cardiomyopathy: The Silent Feline Heart Disease

Hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats and one of the quietest, often producing no outward signs until a sudden crisis of breathing difficulty or hindlimb paralysis. Breeds like Maine Coons and Ragdolls carry known genetic mutations, but the disease also appears unpredictably in cats of no particular pedigree.

A Thickening Muscle Wall

In HCM, the muscular wall of the left ventricle thickens abnormally, reducing the chamber's volume and stiffening it so it cannot relax and fill properly between beats. Unlike dogs, whose heart disease usually involves leaking valves, feline HCM is fundamentally a problem of the heart muscle itself becoming too thick and too stiff.

This impaired filling causes blood to back up into the left atrium, which stretches and enlarges over time, creating a low-flow environment prone to clot formation. A dislodged clot travelling to the aortic bifurcation causes the sudden, agonising hindlimb paralysis known as a saddle thrombus, often the first sign an owner notices.

Why Symptoms Arrive Without Warning

• Sudden, laboured or open-mouthed breathing, sometimes appearing out of nowhere
• Lethargy or reduced activity that is easy to dismiss in an indoor cat
• Sudden hindlimb paralysis, pain and cold paws from a thromboembolism
• A heart murmur or gallop rhythm detected incidentally during a routine exam
• Fainting or collapse episodes during exertion or stress

Because cats mask reduced exercise tolerance simply by moving less, HCM frequently goes unnoticed until a heart murmur is picked up incidentally or a thromboembolic crisis occurs, making routine auscultation at annual check-ups genuinely valuable.

The Role of Screening Echocardiograms

Echocardiography is the definitive diagnostic tool, directly measuring the thickness of the left ventricular wall and the size of the left atrium, both of which guide prognosis. NT-proBNP blood testing offers a useful screening step when a murmur is heard but full echocardiography is not immediately available.

Genetic testing exists for known mutations in Maine Coons and Ragdolls, though many affected cats of other breeds carry no identifiable mutation, so a normal genetic test does not rule out the disease and periodic echocardiograms remain the gold standard for at-risk cats.

Managing Heart Failure and Clot Risk

There is no cure for HCM itself, so treatment aims to manage heart failure symptoms, reduce clot risk and support normal heart rhythm.

• Furosemide to reduce fluid build-up in cats showing signs of congestive heart failure
• Clopidogrel, given long-term to reduce the risk of thromboembolism in cats with an enlarged left atrium
• Pimobendan in select cases to support heart function under specialist guidance
• Beta-blockers such as atenolol for cats with dynamic outflow obstruction or arrhythmias

Living With a Cat on Cardiac Medication

Cats with mild, asymptomatic HCM often need nothing beyond regular echocardiogram monitoring every six to twelve months to track progression, with no restriction on normal indoor activity. Stress reduction is worthwhile, since acute stress can precipitate decompensation in a borderline heart.

Cats on long-term heart medication should have resting respiratory rate checked by the owner regularly, since a sustained rate above 30 breaths per minute at rest is a reliable early warning sign of fluid build-up, well before overt breathing distress develops.

When to seek help urgently

• Open-mouth breathing or a resting respiratory rate consistently above 40 breaths per minute
• Sudden paralysis, dragging, or extreme pain in one or both hindlegs
• Cold hindpaws with no detectable pulse
• Collapse, fainting, or bluish gums

HCM severity ranges from an incidental murmur to a life-threatening emergency, and echocardiographic findings — not symptoms alone — should guide monitoring frequency and medication decisions in consultation with your vet.